Bismuthyl Ecabet | m-entrepreneurship.com

Product Name :
Bismuthyl Ecabet

Search keywords :
Ecabet

drugId :
null

Target Vo:
Protease

Target Vo Short Name :
Protease

Moa_Name:
Protease inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Shanghai Xingkang Medicine Research Development Co Ltd

Active Company_Name :
China Resources Pharmaceutical Group Ltd

Active Indication_Name:
Peptic Ulcer

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 1 Clinical

China Highest Status:
Phase 1 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
CD44 Antibody
ISG15 Antibody
CIDEC Antibody (YA911): CIDEC Antibody (YA911) is an unconjugated, approximately 27 kDa, mouse-derived, anti-CIDEC (YA911) monoclonal antibody. CIDEC Antibody (YA911) can be used for: WB, ICC/IF, FC expriments in human background without labeling.

Author: Betaine hydrochloride

Related Posts